PPXRD-16 – XRD Training for the Pharmaceutical Scientist!
The Pharmaceutical Powder X-ray Diffraction Symposium is designed to create a forum for the exchange of knowledge and cutting-edge ideas among those interested in the combined fields of XRD and pharmaceutical sciences. It typically includes a full-day workshop, followed by several important sessions focused on practical applications of X-ray analysis in the study of pharmaceutical materials. Topics include patent and regulatory issues, formulation, product development, drug delivery, polymorphs, amorphous and nanomaterials, complimentary techniques, and much more.
Since 1999, ICDD has hosted 15 PPXRDs in various parts of the world. The host locations typically rotate and symposiums have been held in USA, Europe, and Asia. The abstracts from previous symposiums are publicly available as well as the presentations, except for the most recent event. The most recent presentations are available to attendees of that year’s event, for one year. After that time, they also become publicly available.
This year’s PPXRD is a joint meeting with the second SPS-XRPD – Spring Pharmaceutical Synchrotron X-ray Powder Diffraction Workshop and will be held in Switzerland at the Paul Scherrer Institute from 9-12 May 2019.
16th Pharmaceutical Powder X-ray Diffraction (PPXRD) Symposium &
Spring Pharmaceutical Synchrotron X-ray Powder Diffraction (SPS-XRPD) Workshop
The 16th Pharmaceutical Powder X-ray Diffraction (PPXRD) Symposium was held as a joint meeting with the Spring Pharmaceutical Synchrotron X-ray Powder Diffraction (SPS-XRPD) Workshop, 9-12 May 2019, at the Paul Scherrer Institute (PSI), in beautiful Villigen, Switzerland.
The joint meeting provided a forum to engage a network of user-facility, academic, and industrial XRD & pharmaceutical scientists in discussions on XRD and related techniques and their application to pharmaceutical science. The Plenary Session, “Intellectual Property Rights, Counterfeit Drugs” was dedicated to the memory of Professor Joel Bernstein (1941-2019), a friend to many attending this meeting and a pioneer in polymorphism studies. Further discussions included recent developments and opportunities in pharmaceutical R&D made possible using synchrotron radiation.
• Intellectual Property Rights
• Counterfeit Drugs
• API Phase Stability
• Qualitative & Quantitative Phase Analysis
• Synchrotron XRPD Beamlines
• Synchrotron Case Studies
• Amorphous, Mesomorphous, and Nanomaterials
• Biological & Biosimilar Drugs
• Pair Distribution Function Guidelines
• Software, Database, Laboratory Instrumentation
• Structure Determination
• Complementary and Emerging Techniques & Methodologies
Taking advantage of our host location, the program included tours of the PSI Large Scale Facilities. Attendees were given the choice to visit the Swiss Light Source (SLS) or the free-electron X-ray laser SwissFEL. A poster session was held concurrently with the technical talks, along with an exhibition of XRPD vendors.
Our sincere thanks to the following organizations for their participation:
• Avant-garde Materials Simulation GmbH
• Bruker Nano
• Malvern Panalytical
The event offered many opportunities for networking throughout the symposium including some formal social gatherings, such as an opening night reception, and a delightful symposium dinner.
ICDD would like to express its thanks and appreciation to the Paul Scherrer Institute and Park innoVAARE for their hospitality in hosting our event.
PPXRD-16 and SPS-XPPD-2 Registration is now closed.
For questions or concerns regarding the symposium registration, please contact Denise Zulli: email@example.com. Please note, there is no registration offered on-site at the symposium.
Registration will not be conducted on-site. All attendees must pre-register for the symposium. Registration ends on 22 April 2019.
|Early Registration Discount
(Now until 8 April)
(8 -22 April)
Please note: Lunches, coffee breaks, receptions and the Friday evening Conference Dinner are included in the registration fee.
Student Identification required. Students should fill out a Registration Form and submit to ICDD with a copy of their Student Identification.
A 50% refund will be issued, if the cancellation is received by ICDD in writing no later than 25 April 2019
(Email: firstname.lastname@example.org). No refunds will be issued for cancellations received after that date; however, with advance notice, you may transfer your registration to a colleague.
Rooms are limited and will sell out quickly. Please do not delay in making your reservation.
A block of rooms has been reserved for Wednesday evening, 8 May 2019 until Sunday morning, 12 May 2019 for attendees of the PPXRD-16 & SPS-XRPD-2 symposium at the Hotel Terminus Brugg in Switzerland.
All rooms are equipped with private bath and toilet – or shower and toilet, TV/Radio, Fridge (with a free Welcome-Drink every day), and free Internet (WLAN) from Swisscom inside the building.
If possible, please use the hotel’s on-line form “Contact” to reserve your room(s).
Room Categories and Prices
Rooms & Fees for 1 person:
CHF 120.-/night: Smaller, older, budget room
CHF 125.-/night: “Standard” single room
*CHF 158.-/night: Newly built, “comfort” room
*CHF 160.-/night: “Superior” room with bathtub and shower.
Rooms & Fees for 2 persons:
CHF 190.-/night: “Standard” for 2 people with bathtub
*CHF 230.-/night: Newly built, “Superior” with bathtub and shower
*New rooms only for non-smoking!
Included in the price!
- Buffet Breakfast (daily open from 6am till 9am)
- Free Internet (WLAN) in the rooms
- Free Hotel parking – and all taxes and fees
- All prices are net Hotel and are also valid for the year 2019!
Please visit the hotel’s website to learn more about services and room options:
Hotel Terminus Brugg AG
Phone: +4156 460 25 25
Spring Pharmaceutical Synchrotron X-ray Powder Diffraction Workshop
Laboratory powder diffraction is a proven and trusted technique for pharma R&D but synchrotron powder diffraction pushes beyond the capabilities of conventional instrumentation. SPS-XRPD is joining with PPXRD to highlight the most exciting recent developments and opportunities in pharmaceutical R&D made possible by synchrotron XRPD. The joint meeting offers the chance to engage an active network of synchrotron, academic and industrial pharmaceutical scientists, promote awareness of this technique and lower the barriers to access synchrotron XRPD and total scattering techniques.
Visit the SPS-XRPD-1 website to view information from the first workshop held at Purdue University in May 2018.
Dr. Fabia Gozzo, Excelsus Structural Solutions (Swiss) AG, Switzerland
Prof. Stephen R. Byrn, Department of Industrial and Physical Pharmacy, Purdue University, USA
Dr. Chris J. Benmore, Advanced Photon Source, Argonne National Laboratory, USA
Mr. Stefan Müller, Paul Scherrer Institute, Switzerland
Dr. Benno Rechsteiner, Park Innovaare, Switzerland
Dr. Mathilde Reinle-Schmitt, Excelsus Structural Solutions (Swiss) AG, Switzerland
Dr. Pamela A. Smith, Improved Pharma, USA
In conjunction with the upcoming joint PPXRD-16/SPS-XRPD-2 meeting taking place from the 9th to the 12th May 2019 in Switzerland, Excelsus Structural Solutions launches a program of ‘case studies’. This program gives 5 selected pharmaceutical companies the opportunity to explore for free the capabilities offered by Synchrotron XRPD on a real industrial problem. Examples include purity assessment of APIs or formulations, trace analyses, quantitative phase analysis, amorphous quantification.
The results would then be presented in a dedicated session of the conference and act as sources of inspiration to nurture new and innovative ideas based around the unique potential of Synchrotron X-ray Powder Diffraction. More details about the company and the program are available in the attached brochure. Think outside the box and challenge us!
For questions or assistance regarding the Case Studies Program, please contact:
Reserve your exhibit space at PPXRD-16 and SPS-XRDPD-2
9-12 May 2019 | Exhibit 10-12 May 2019
Paul Scherrer Institute, Villigen, Switzerland
Space is limited – reserve your spot today!
Abstracts are hereby solicited for any of the following oral sessions, or the evening poster session.
Deadline for Submission of Abstracts: 29 March 2019
- Opening Plenary, Industry Speaks to Academia (invited talks only)
- Plenary Session, Intellectual Property Rights, Counterfeit Drugs (invited talks only)
- API Phase Stability
- Qualitative & Quantitative Phase Analysis
- Amorphous, Mesomorphous, Nano Materials
- Synchrotron XRPD Beamlines Overview
- Structure Determination
- Software, Database, Laboratory Instrumentation
- Biological & Biosimilar Drugs
- Complementary and Emerging Techniques and Methodologies
GUIDELINES FOR PREPARING ABSTRACTS
Abstracts will be printed in the Symposium Book of Abstracts and will also be posted on the ICDD web site. Abstracts must not exceed one page in length and must include the title, author(s), affiliation(s), and the text. To provide uniformity, it is recommended that abstracts be prepared according to the following guidelines:
- File format: The Abstract should be submitted as either a Microsoft® Word document (Word 2013 – Word 2016) or a PDF file (Portable Document File).
- The PDF or Word doc of the abstract must include the title, author(s), affiliations(s) and text. The general information form that you complete does not automatically add the title and author information to the abstract.
- Size: The abstract should not exceed one page in length (8.5” x 11” page size); with a one-inch margin all around. This includes any figures or graphs (please keep to a minimum).
- Font: Times or Times New Roman, 10 or 12 point.
- Title: Bold, Center, Mixed upper and lower case.
- Author(s), Affiliation(s) and Contact Author’s E-mail Address: Center directly under Title. Leave one blank line after Contact Author’s E-mail Address before beginning text of abstract.
- Text: Paragraphs should be flush left (do not indent); single-spaced; leave one blank line between paragraphs, space permitting.
- Characters, tables, formulae, figures, symbols, graphics: All must be embedded into your text. Please keep to a minimum, and limit the fonts to those that are available with the standard distribution of Microsoft® Word. Non-standard fonts will lead to errors in transmission.
Abstracts will only be accepted through the online submission process. You will be required to fill out a general information form, and then given a choice to either upload your abstract directly from your computer as a PDF file or e-mail your abstract as an attachment created in Microsoft® Word (Word 2013 – Word 2016). The information you upload on the general information form is not considered a part of your abstract. You must still include the title and author information in the actual abstract file.
When submitting your abstract online, you will receive an automated e-mail confirmation. If you choose to e-mail your abstract as a Microsoft® Word document, then confirmation of your abstract may take up to one week. If you do not receive confirmation within one week of your submittal, please contact Denise Zulli: email@example.com; 610-325-9814.
The Call for Abstracts has ended. If you are looking for an opportunity to present at the symposium, please contact Denise Zulli: firstname.lastname@example.org.
Dr. Tom Blanton, Chair, International Centre for Diffraction Data, Newtown Square, PA, USA
Dr. Detlef Beckers, Malvern Panalytical, Almelo, The Netherlands
Dr. Graciela C.D. de Delgado, University de Los Andes, Merida, Venezuela
Dr. Julien Giovannini, AstraZeneca R&D, Sweden
Dr. Fabia Gozzo, Excelsus Structural Solutions sprl, Switzerland and Belgium
Dr. Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
Ms. Terry Maguire, International Centre for Diffraction Data, Newtown Square, PA, USA
Dr. Keisuke Saito, Rigaku Americas, Houston, TX, USA
Dr. Gregory A. Stephenson, Crystal Pharmatech Inc., Fishers, IN, USA
Dr. Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, USA
Dr. Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, USA
Local Organizer for PPXRD-16
Mathilde Reinle-Schmitt, Mickael Morin and Barbara Ramirez, Excelsus Structural Solutions (Swiss) AG
PPXRD-15 – 18-20 August 2017 – PPXRD-15 Program
PPXRD-14 – 6-9 June 2016 – PPXRD-14 Program
Sanibel Harbour Marriott
Fort Myers, Florida, USA
PPXRD-13 – 18-21 May 2015 – PPXRD-13 Program
Bad Herrenalb, Germany
PPXRD-12 – 20-24 May 2013 – PPXRD-12 Program
Institute of Physics, Chinese Academy of Sciences
PPXRD-11 – 15-18 May 2012 – PPXRD-11 Program
Sanibel Harbour Marriott Resort & Spa
Fort Myers, Florida, USA
PPXRD-10 – 16-19 May 2011 – PPXRD-10 Program
PPXRD-9 – 22–25 February 2010 – PPXRD-9 Program
Hilton Head Island, South Carolina, USA
PPXRD-8 – 4-7 May 2009 – PPXRD-8 Program
Glasgow, Scotland, U.K
PPXRD-7 – 25-28 February 2008 – PPXRD-7 Program
Orlando, FL, U.S.A.
PPXRD-6 – 19-22 February 2007 – PPXRD-6 Program
PPXRD-5 – 14-16 February 2006 – PPXRD-5 Program
Somerset, New Jersey, USA
PPXRD-4 – 21-24 February 2005 – PPXRD-4 Program
PPXRD-3 – 23-25 February 2004 – PPXRD-3 Program
Hilton Head Island, South Carolina, USA
PPXRD-2 – 9-12 December 2002 – PPXRD-2 Program
Concordville, PA, USA
PPXRD-1 – 27-29 September 1999 – PPXRD-1 Program
Newtown Square, PA, USA